CAPACITIVE AND RESISTIVE 448kHz Radiofrequency

González de Vega C; Martínez C; García A; Hasko M; Barba S; Horcajo MV; Buenaventura M.

MEDYR Clinic, Madrid, Spain.
HUMAN TECAR is a unique therapeutic treatment that
combines manual therapy and deep diathermia
radiofrequency (448 kHz) transferred to the patient in
two ways:
1. Capacitive (CAP): electrical transference: with isolated
CAP RES
electrodes.
2. Resistive (RES): electrical transference: with metallic
electrodes.
MECHANISM OF ACTION:
1. Increase microcirculation.
Global results
RESULTS NUM. OF PATIENTS
2. Increase vasodilatation.
Good 364
3. Increase temperature.
Average 106
After diagnostic procedures, treatment with TECAR Bad 43

was established. N/A 22

We use 2 TECAR HCR902(*) devices provided with

the CAP/RES techniques.
Parameters were adjusted individually, depending on
type of injury, chronicity, etc…
We applied a 15´ therapy on a daily base.
Concomitant treatments: manual therapy.
Pharmacological therapy: painkillers.

Capacitive and Resistive 448kHz Radiofrequency

therapy was applied in 535 patients. Recruited from
April 2008 to April 2010. We have divided them in 15
different pathology groups:
Ankle injuries; arthritis; cervical-dorsal pathology; Cx y Fx locomotive
apparatus; dislocations and instabilities; knee: Ligaments/ meniscus
and others; muscle torn; muscular strains: contractures/ pain; neural
injuries; plantar fasciitis; pyramidal syndrome/ lumbago/sciatica;
scars/ wounds/ haematomas; elbows tendon injuries ; low limbs
Evolution %
tendon injuries; shoulders tendon injuries.
The mean age of the sample was: 42.1 years (from 9
to 86 years), from those 246 were females and 289
males. 484 acute injuries (90,5%) and 51 chronic
injuries (9,5%).
We applied three different evolution assessment
criteria:
1. VAS (Visual Analogue Scale) for pain (1 to 10):
Good: VAS: 0-2, normal mobility & activity.
Average: VAS: 2-5, mobility & activity with some limitation.
Poor: VAS > 5, important limitation in mobility and activity.
2. Mobility recovery level (1 to 5).
3. Activity recovery level (1 to 5).

CONCLUSIONS:
HUMAN TECAR provides an useful treatment for faster injuries rehabilitation.
HUMAN TECAR therapy can be used at the same time than manual therapies. The treatment is more efficient performed
on short time sessions, but on a daily base.
HUMAN TECAR seems to be specially efficient on soft tissues pathologies.
The results show that HUMAN TECAR therapy is more effective in acute and sub-acute injuries.
HUMAN TECAR therapy is very well tolerated by the patient.
It is essential to go farther in the treatment of chronic injuries.
We have to go forward in a deeper investigation in order to improve the knowledge of HUMAN TECAR and its effects.